News and Trends 24 Aug 2022
Clearance given to clinical trial with potential to change course of brain disease
…functional and cognitive decline.” BV-101 is a novel, exclusively designed adeno-associated virus (AAV) gene therapy vector that simultaneously addresses the metabolic dysfunction of diseased neurons as well as contributes to…